Clinical Trial

Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia

Study acronym: NAC/ALA
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The current study is to investigate the potential roles of N-acetyl cysteine and Alpha-lipoic acid in patients with beta-thalassemia.
Trial Details
NCT Number NCT07157722
Lead Sponsor Tanta University
Conditions Beta Thalassemia
Enrollment 66 participants
Start Date 2025-08-30
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-05